Jeffrey Black compensation by year
STANDARD BIOTOOLS Summary Compensation Table · all 2 fiscal years held| Component | FY2023 | FY2024 |
|---|---|---|
| Salary | $259,375 | $291,250 |
| Bonus | $0 | $0 |
| Stock awards | $400,000 | $774,000 |
| Option awards | $558,272 | $808,442 |
| Non-equity incentive | $273,900 | $0 |
| Pension and deferred compensation | $0 | $0 |
| All other | $750 | $16,955 |
| Total | $1,492,297 | $1,890,647 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: STANDARD BIOTOOLS INC. DEF 14A filed April 30, 2025, accession 0001140361-25-016515, and prior-year filings. Open the filing on EDGAR.
How this page was built: the STANDARD BIOTOOLS INC. filed document, accession 0001140361-25-016515. Every figure is read from that document and cited to the page and table it appears in. Filed April 30, 2025.
Equity holdings
unvested awards at FY2023 year-end| Type | Unvested units | Value at year-end | Exercise price |
|---|---|---|---|
| RSU | 210,549 | $465,313 | — |
| Option | 400,000 | — | $1.90 |
Per the Outstanding Equity Awards at Fiscal Year-End table in STANDARD BIOTOOLS INC.'s FY2023 proxy; value at the fiscal year-end close, as the company printed it.
STANDARD BIOTOOLS’s named executive officers, FY2024
as the company reported each| Named executive officer | Role | FY2024 total |
|---|---|---|
| Michael Egholm | President, Chief Executive Officer, and Director | $8,337,044 |
| Sean Mackay | Chief Business Officer | $3,177,155 |
| Alex Kim | Chief Financial Officer | $3,090,340 |
| Jeffrey Black · this page | Former Chief Financial Officer | $1,890,647 |
The full STANDARD BIOTOOLS compensation record
free company briefThis page is one person within STANDARD BIOTOOLS's record. The company brief lists every named executive, each linking to their own page.
Peer companies
named in the STANDARD BIOTOOLS proxy · each links to its own free briefCompensation, the day it’s disclosed
The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.
How this record is built
Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are STANDARD BIOTOOLS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.